Alder BioPharmaceuticals Appoints Erin Lavelle to New COO Role

Xconomy Seattle — 

Alder BioPharmaceuticals (NASDAQ: ALDR) has named Erin LaVelle to the newly created position of chief operating officer. Before joining Bothell, WA-based Alder, Lavelle was the general manager of the Taiwanese affiliate of Amgen (NASDAQ: AMGN). Alder says Lavelle will lead strategy and planning as the company prepares to bring its migraine drug, eptinezumab, to the market. The company has said it expects to file for FDA approval of the migraine drug later this year.